As global markets experience a boost from cooling inflation and robust bank earnings, value stocks have notably outperformed growth shares, particularly in the U.S. This environment presents an opportunity to explore stocks that may be undervalued, as investors seek to capitalize on sectors showing resilience and potential for recovery amidst these economic shifts.
Name | Current Price | Fair Value (Est) | Discount (Est) |
Aidma Holdings (TSE:7373) | ¥1753.00 | ¥3613.36 | 51.5% |
Alltop Technology (TPEX:3526) | NT$264.50 | NT$526.96 | 49.8% |
Atlantic Union Bankshares (NYSE:AUB) | US$37.87 | US$75.40 | 49.8% |
Fevertree Drinks (AIM:FEVR) | £6.575 | £13.12 | 49.9% |
Sudarshan Chemical Industries (BSE:506655) | ₹1112.30 | ₹2216.41 | 49.8% |
Vestas Wind Systems (CPSE:VWS) | DKK92.60 | DKK184.75 | 49.9% |
Shinko Electric Industries (TSE:6967) | ¥5850.00 | ¥11654.66 | 49.8% |
St. James's Place (LSE:STJ) | £9.315 | £18.60 | 49.9% |
Condor Energies (TSX:CDR) | CA$1.82 | CA$3.63 | 49.8% |
Coeur Mining (NYSE:CDE) | US$6.36 | US$12.67 | 49.8% |
Click here to see the full list of 863 stocks from our Undervalued Stocks Based On Cash Flows screener.
Here we highlight a subset of our preferred stocks from the screener.
Overview: Bonesupport Holding AB is an orthobiologics company that develops and commercializes injectable bio-ceramic bone graft substitutes across Europe, North America, and internationally, with a market cap of SEK24.81 billion.
Operations: The company's revenue segment is primarily derived from Pharmaceuticals, amounting to SEK814.46 million.
Estimated Discount To Fair Value: 22.8%
Bonesupport Holding is trading at SEK 373.4, which is over 20% below its estimated fair value of SEK 483.97, indicating it may be undervalued based on discounted cash flow analysis. Despite a drop in profit margins from 41% to 11.1%, the company shows strong revenue growth forecasts of 33.8% annually, outpacing the Swedish market significantly. Recent positive clinical study results for CERAMENT products could further enhance its market position and drive future growth.
Overview: Guobo Electronics Co., Ltd. is involved in the R&D, production, and sale of active phased array transmitter and receiver components as well as radio frequency integrated circuit products in China, with a market cap of CN¥26.89 billion.
Operations: Guobo Electronics generates revenue primarily through the sale of active phased array transmitter and receiver components and radio frequency integrated circuit products in China.
Estimated Discount To Fair Value: 12.9%
Guobo Electronics, trading at CN¥46.89, is priced below its estimated fair value of CN¥53.85, suggesting undervaluation based on cash flows. Despite a decline in nine-month revenue to CN¥1.81 billion from the previous year's CN¥2.83 billion and net income dropping to CN¥306.41 million, earnings are forecasted to grow significantly at 26.9% annually over the next three years, outpacing both profit and revenue growth compared to the broader Chinese market.
Overview: Sodick Co., Ltd. develops, manufactures, and sells numerical control electric discharge machines (EDMs) and has a market cap of ¥40.75 billion.
Operations: The company's revenue is primarily derived from its Machine Tool Business at ¥48.73 billion and Industrial Machinery at ¥8.76 billion, with additional contributions from the Food Machine segment totaling ¥5.86 billion.
Estimated Discount To Fair Value: 28.6%
Sodick, trading at ¥818, is undervalued compared to its estimated fair value of ¥1,145.62. Its earnings are expected to grow significantly by 92.47% annually over the next three years, surpassing market averages and leading to profitability. However, its return on equity is projected to remain low at 4.4%. Recent buyback activity totaling ¥176.1 million for 240,900 shares aims to enhance shareholder value amid a challenging business environment.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include OM:BONEX SHSE:688375 and TSE:6143.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。